logo
Plus   Neg
Share
Email

EARNINGS SUMMARY: Details of Array BioPharma Inc. Q3 Earnings Report

Below are the earnings highlights for Array BioPharma Inc. (ARRY):

-Earnings: -$37.49 million in Q3 vs. -$22.85 million in the same period last year.
-EPS: -$0.17 in Q3 vs. -$0.11 in the same period last year.
-Analysts projected -$0.20 per share
-Revenue: $64.68 million in Q3 vs. $66.37 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT